Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization

This publication has 38 references indexed in Scilit:

• Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect againstBacillus anthracisInfection and Enhance Endogenous Immunity to Anthrax
  Infection and Immunity, 2007
• Contributions of Histamine, Prostanoids, and Neurokinins to Edema Elicited by Edema Toxin fromBacillus anthracis
  Infection and Immunity, 2007
• Bacillus anthracisEdema and Lethal Toxin Have Different Hemodynamic Effects but Function Together to Worsen Shock and Outcome in a Rat Model
  The Journal of Infectious Diseases, 2007
• Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum
  Journal of Pharmaceutical and Biomedical Analysis, 2007
• Protective Antigen and Toxin Neutralization Antibody Patterns in Anthrax Vaccinees Undergoing Serial Plasmapheresis
  Clinical and Vaccine Immunology, 2005
• Human-derived, plant-produced monoclonal antibody for the treatment of anthrax
  Vaccine, 2005
• Mass Value Assignment of Total and Subclass Immunoglobulin G in a Human Standard Anthrax Reference Serum
  Clinical and Vaccine Immunology, 2004
• Validation of the anthrax lethal toxin neutralization assay
  Biologicals, 2004
• Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States
  Emerging Infectious Diseases, 2001
• Neurological and Physiological Responses of the Primate to Anthrax Infection
  The Journal of Infectious Diseases, 1968